Suppr超能文献

在接受手术治疗的原发性与继发性甲状旁腺功能亢进患者中诊断出的并存甲状腺乳头状癌:发病率相同,特征不同。

Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics.

作者信息

Preda Cristina, Branisteanu Dumitru, Armasu Ioana, Danila Radu, Velicescu Cristian, Ciobanu Delia, Covic Adrian, Grigorovici Alexandru

机构信息

Faculty of Medicine, Department of Endocrinology, "Gr igore T Popa" University of Medicine and Pharmacy, 16 Universitatii Str, 700115, Iasi, Romania.

Department of Morphofunctional Sciences, "Grigore T. Popa" University of Medicine, Iasi, Romania.

出版信息

BMC Surg. 2019 Jul 16;19(1):94. doi: 10.1186/s12893-019-0556-y.

Abstract

BACKGROUND

The coexistence of hyperparathyroidism and thyroid cancer presents important diagnostic and management challenges. With minimally invasive parathyroid surgery trending, preoperative thyroid imaging becomes more important as concomitant thyroid and parathyroid lesions are reported. The aim of the study was to evaluate the rate of thyroid cancer in patients operated for either primary (PHPT) or secondary hyperparathyroidism (SHPT).

METHODS

Our retrospective study included PHPT and SHPT patients submitted to parathyroidectomy and, when indicated, concomitant thyroid surgery between 2010 and 2017.

RESULTS

Parathyroidectomy was performed in 217 patients: 140 (64.5%) for PHPT and 77 (35.5%) for SHPT. Concomitant thyroid surgery was performed in 75 patients with PHPT (53.6%), and 19 papillary thyroid carcinomas (PTC) were found, accounting for 13.6% from all cases with PHPT and 25.3% from PHPT cases with concomitant thyroid surgery. Thirty-one of operated SHPT patients (40.3%) also underwent thyroid surgery and 9 PTC cases were diagnosed (11.7% of all SHPT patients and 29% of patients with concomitant thyroid surgery). We found differences between PHPT and SHPT patients (p < 0.001) with respect to age (54.6 ± 13y versus 48.8 ± 12y), female-to-male ratio (8:1 versus ~ 1:1), surgical technique (single gland parathyroidectomy in 82.8% PHPT cases; versus subtotal parathyroidectomy in 85.7% SHPT cases) and presurgical PTH (357.51 ± 38.11 pg/ml versus 1020 ± 161.38 pg/ml). Morphopathological particularities, TNM classification and multifocality incidence of PTC were similar in the two groups. All PTC from patients with SHPT were thyroid microcarcinomas (TMC, i.e. tumors with a diameter smaller than 1 cm), whereas seven out of the 19 cases with PTC and PHPT were larger than 1 cm.

CONCLUSIONS

PTC was frequently and similarly associated with both PHPT and SHPT irrespective of presurgical PTH levels. Thyroid tumors above 1 cm were found only in patients with PHPT. Investigators should focus also on associated thyroid nodular pathology in patients with PHPT.

摘要

背景

甲状旁腺功能亢进与甲状腺癌并存带来了重要的诊断和管理挑战。随着微创甲状旁腺手术的兴起,由于有报道称甲状腺和甲状旁腺病变并存,术前甲状腺成像变得更加重要。本研究的目的是评估接受原发性甲状旁腺功能亢进(PHPT)或继发性甲状旁腺功能亢进(SHPT)手术患者的甲状腺癌发生率。

方法

我们的回顾性研究纳入了2010年至2017年间接受甲状旁腺切除术的PHPT和SHPT患者,必要时还包括同期进行的甲状腺手术患者。

结果

217例患者接受了甲状旁腺切除术:140例(64.5%)为PHPT,77例(35.5%)为SHPT。75例PHPT患者(53.6%)同期进行了甲状腺手术,发现19例甲状腺乳头状癌(PTC),占所有PHPT病例的13.6%,占同期进行甲状腺手术的PHPT病例的25.3%。31例接受手术的SHPT患者(40.3%)也进行了甲状腺手术,诊断出9例PTC病例(占所有SHPT患者的11.7%,占同期进行甲状腺手术患者的29%)。我们发现PHPT和SHPT患者在年龄(54.6±13岁对48.8±12岁)、男女比例(8:1对约1:1)、手术技术(82.8%的PHPT病例行单腺甲状旁腺切除术;85.7%的SHPT病例行甲状旁腺次全切除术)和术前甲状旁腺激素水平(357.51±38.11pg/ml对1020±161.38pg/ml)方面存在差异(p<0.001)。两组PTC的形态病理学特征、TNM分类和多灶性发生率相似。所有SHPT患者的PTC均为甲状腺微小癌(TMC,即直径小于1cm的肿瘤),而19例PTC合并PHPT患者中有7例直径大于1cm。

结论

无论术前甲状旁腺激素水平如何,PTC在PHPT和SHPT中均频繁且相似地与之相关。仅在PHPT患者中发现直径大于1cm的甲状腺肿瘤。研究人员也应关注PHPT患者的相关甲状腺结节病理情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619a/6636032/80aa6bdbe1c0/12893_2019_556_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验